Myomo (MYO)
(Delayed Data from AMEX)
$3.64 USD
-0.19 (-4.96%)
Updated May 13, 2024 04:00 PM ET
After-Market: $3.62 -0.02 (-0.55%) 5:22 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Myomo, Inc. [MYO]
Reports for Purchase
Showing records 41 - 60 ( 118 total )
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
1Q:21 Results Exceed Our Estimates,Forecast Expanded Reimbursement, International Sales Will Fuel Sales Acceleration In 2021 And 2022; Maintain $23 Price Target
Provider: SIDOTI CSR
Analyst: Research Department
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
International Prospects Improving; We Estimate Expanded Reimbursement That Will Fuel More Than 50% Annual Revenue Growth In 2021
Provider: SIDOTI CSR
Analyst: Research Department
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
Estimate Expanded Reimbursement, Wider Distribution Will Fuel Sales Acceleration In 2021 And 2022
Provider: SIDOTI CSR
Analyst: Research Department
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
3Q:20 Results Exceed Our Estimates; Maintain BUY Rating, $11 Price Target
Provider: SIDOTI CSR
Analyst: Research Department
Company: Myomo, Inc.
Industry: Medical - Products
3Q20 Recap - Upgrading on Momentum and Expanded Runway
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
Myomo Achieves Another Milestone Toward Obtaining Medicare Coverage,Maintain $11 Target
Provider: SIDOTI CSR
Analyst: Research Department
Company: Myomo, Inc.
Industry: Medical - Products
Company: Myomo, Inc.
Industry: Medical - Products
2Q:20 Results Ahead Of Our Estimates And Updated Guidance
Provider: SIDOTI CSR
Analyst: Research Department